Multiparameter battery state estimator based on adaptive direct solution different equation.docx
《Multiparameter battery state estimator based on adaptive direct solution different equation.docx》由会员分享,可在线阅读,更多相关《Multiparameter battery state estimator based on adaptive direct solution different equation.docx(99页珍藏版)》请在冰豆网上搜索。
![Multiparameter battery state estimator based on adaptive direct solution different equation.docx](https://file1.bdocx.com/fileroot1/2023-7/20/99480a68-dce7-4ad2-9c2e-ca385deca34a/99480a68-dce7-4ad2-9c2e-ca385deca34a1.gif)
Multiparameterbatterystateestimatorbasedonadaptivedirectsolutiondifferentequation
Newtestmethodwiththeaimtoevaluatethetribologyinpowderdiecompaction.►Testmethodutilizesacommercialscratchtester.►Smalltestsamplespromotepost-testmicroscopyandsurfaceanalysis.►Tribo-inducedmechanismsaremonitoredbyfrictionandacousticemissionsignals.►Promisingscreeningtestforcandidatedietoolmaterials.
267
CornealRefractivePowerandItsAssociationswithOcularandGeneralParameters:
TheCentralIndiaEyeandMedicalStudy OriginalResearchArticle
Ophthalmology,Volume118,Issue9,September2011,Pages1805-1811
JostB.Jonas,VinayNangia,AjitSinha,RajeshGupta
Closepreview | Supplementarycontent
| Relatedarticles | Relatedreferenceworkarticles
AbstractAbstract|Figures/TablesFigures/Tables|ReferencesReferences
Purpose
Toinvestigatethenormaldistributionofcornealrefractivepower(CRP)anditsassociationswithotherocularandsystemicparametersintheCentralIndianpopulation.
Design
Population-basedstudy.
Participants
TheCentralIndiaEyeandMedicalStudyisapopulation-basedstudyperformedinaruralregionofCentralIndia.Thestudycomprised4711subjectsaged30+years.
Methods
Adetailedophthalmicandmedicalexaminationwasperformed.HorizontalandverticalCRPweremeasuredusinganon-automatickeratometer.
MainOutcomeMeasures
Cornealrefractivepower.
Results
Afterexcludingpseudophakicoraphakiceyes,keratometricmeasurementswereavailableon9024eyesof4617studyparticipants(98.0%)withameanageof49.1±13.2years(range,30–100years)andameanrefractiveerrorof−0.20±1.52diopters(D).MeanhorizontalCRPwas44.60±1.68D(mean±standarddeviation;range,36.5–52.0D),andverticalCRPwas44.62±1.74D(range,37.75–52.0D)withnosignificantdifferencebetweenbothparameters(P=0.27).Inmultivariateanalysis,CRPwassignificantly(P<0.001)associatedwiththesystemicparametersofincreasingage(P<0.001),lowerlevelofeducation(P=0.02),andlowerbodyheight(P<0.001),andwiththeocularparametersofthinnercentralcornealthickness(P<0.001),deeperanteriorchamber(P<0.001),shorteraxiallength(P<0.001),andmyopicrefractiveerror(P<0.001).TheresultsremainedunchangedifeyeswithCRP≥48Dwereexcluded.
Conclusions
HorizontalCRPincreasedwithhigherage,lowerlevelofeducation,lowerbodyheight,thinnercentralcornea,deeperanteriorchamber,shorteraxiallength,andmyopicrefractiveerror.Theassociationwithagemaybeofimportanceforrefractivesurgery.Theassociationofasteepercorneawithashorterbodystatureandashorteraxiallengthparallelsanassociationbetweenshorterbodylengthandshorteraxiallengthwithoutassociationwithrefractiveerror.Theassociationamongsteepercornea,shorterbodylength,andlowereducationallevelcomplementstheassociationbetweenshorterbodylengthandlowereducationallevel.Thecorrelationbetweensteepercorneaanddeeperanteriorchambermaybeexplainedgeometrically.
FinancialDisclosure(s)
Theauthor(s)havenoproprietaryorcommercialinterestinanymaterialsdiscussedinthisarticle.
ArticleOutline
MaterialsandMethods
Results
Discussion
StudyLimitations
Supplementarydata
References
Purchase
268
Techno-economicevaluationofmembranetechnologyforpre-combustiondecarbonisation:
Water-gasshiftversusreforming OriginalResearchArticle
EnergyProcedia,Volume4,2011,Pages723-730
JanWilcoDijkstra,GunabalanRaju,GerardPeppink,DanielJansen
Closepreview |
PDF(344K) | Relatedarticles | Relatedreferenceworkarticles
AbstractAbstract|ReferencesReferences
Abstract
Atechno-economicevaluationoftheapplicationofmembranereactorsinnaturalgascombinedcycleswithCO2captureispresented.Theelectricalefficiency,captureefficiency,requiredmembranesurfaceareaandcostofCO2avoidedarepresentedforpowerplantsintegratedwithmembranereformersaswellasmembranewatergasshiftreactors.ForapplicationsinCO2capture,membranewater-gas-shiftismoresuitedthanmembranereforming.ThelowerhydrogenpartialpressureinamembranereformercomparedtomembraneWGScauseshighinvestmentcosts,becausethemembraneareaishighandcompressionofthehydrogenfuelbeforeenteringthegasturbineisnecessary.Asignificantincreaseinoperatingtemperature,possiblycombinedwithahigherfeedpressurecouldimprovetheperformanceofmembranereformers.Forthevariousoptionsofupstreamreforminginmembranewater-gasshift,gasheatedreformingisthepreferredoptionwithautothermalreformingassecondbest.
269
RandomizedComparisonofSystemicAnti-inflammatoryTherapyVersusFluocinoloneAcetonideImplantforIntermediate,Posterior,andPanuveitis:
TheMulticenterUveitisSteroidTreatmentTrial OriginalResearchArticle
Ophthalmology,InPress,CorrectedProof,Availableonline15August2011
TheMulticenterUveitisSteroidTreatment(MUST)TrialResearchGroupWritingCommittee,JohnH.Kempen,MichaelM.Altaweel,JanetT.Holbrook,DouglasA.Jabs,ThomasA.Louis,ElizabethA.Sugar,JenniferE.Thorne
Closepreview | Supplementarycontent
| Relatedarticles | Relatedreferenceworkarticles
AbstractAbstract|Figures/TablesFigures/Tables|ReferencesReferences
Objective
Tocomparetherelativeeffectivenessofsystemiccorticosteroidsplusimmunosuppressionwhenindicated(systemictherapy)versusfluocinoloneacetonideimplant(implanttherapy)fornoninfectiousintermediate,posterior,orpanuveitis(uveitis).
Design
Randomizedcontrolledparallelsuperioritytrial.
Participants
Patientswithactiveorrecentlyactiveuveitis.
Methods
Participantswererandomized(allocationratio1:
1)tosystemicorimplanttherapyat23centers(3countries).Implant-assignedparticipantswithbilateraluveitiswereassignedtohaveeacheyethatwarrantedstudytreatmentimplanted.Treatment-outcomeassociationswereanalyzedbyassignedtreatmentforalleyeswithuveitis.
MainOutcomeMeasures
Maskedexaminersmeasuredtheprimaryoutcome:
changeinbest-correctedvisualacuityfrombaseline.Secondaryoutcomesincludedpatient-reportedqualityoflife,ophthalmologist-gradeduveitisactivity,andlocalandsystemiccomplicationsofuveitisortherapy.ReadingCentergradersandglaucomaspecialistsassessingocularcomplicationsweremasked.Participants,ophthalmologists,andcoordinatorswereunmasked.
Results
Onevaluationofchangesfrombaselineto24monthsamong255patientsrandomizedtoimplantandsystemictherapy(479eyeswithuveitis),theimplantandsystemictherapygroupshadanimprovementinvisualacuityof+6.0and+3.2letters(P=0.16,95%confidenceintervalondifferenceinimprovementbetweengroups,−1.2to+6.7letters,positivevaluesfavoringimplant),animprovementinvision-relatedqualityoflifeof+11.4and+6.8units(P=0.043),achangeinEuroQol-EQ5Dhealthutilityof+0.02and−0.02(P=0.060),andresidualactiveuveitisin12%and29%(P=0.001),respectively.Overthe24monthperiod,implant-assignedeyeshadahigherriskofcataractsurgery(80%,hazardratio[HR]=3.3,P<0.0001),treatmentforelevatedintraocularpressure(61%,HR=4.2,P<0.0001),andglaucoma(17%,HR=4.2,P=0.0008).Patientsassignedtosystemictherapyhadmoreprescription-requiringinfectionsthanpatientsassignedtoimplanttherapy(0.60vs0.36/person-year,P=0.034),withoutnotablelong-termconsequences;systemicadverseoutcomesotherwisewereunusualinbothgroups,withminimaldifferencesbetweengroups.
Conclusions
Ineachtreatmentgroup,meanvisualacuityimprovedover24months,withneitherapproachsuperiortoadegreedetectablewiththestudy'spower.Therefore,thespecificadvantagesanddisadvantagesidentifiedshoulddictateselectionbetweenthealternativetreatmentsinconsiderationofindividualpatients'particularcircumstances.Systemictherapywithaggressiveuseofcorticosteroid-sparingimmunosuppressionwaswelltolerated,suggestingthatthisapproachisreasonablysafeforlocalandsystemicinflammatorydisorders.
FinancialDisclosure(s)
Proprietaryorcommercialdisclosuremaybefoundafterthereferences.
ArticleOutline
MaterialsandMethods
StudyDesign
EnrollmentofParticipants,DataCollection,andFollow-up
RandomTreatmentAssignment
Treatment
OutcomesandMasking
SampleSizeDetermination
StatisticalAnalyses
Results
VisualFunction
UveitisActivityandMacularEdema
OcularandSystemicComplications
QualityofLife
Discussion
Supplementarydata
References
Purchase
270
DifferentialImprovementsinLipidProfilesandFraminghamRecurrentRiskScoreinPatientsWithandWithoutDiabetesMellitusUndergoingLong-TermCardiacRehabilitation OriginalResearchArticle
ArchivesofPhysicalMedicineandRehabilitation,Volume92,Issue9,September2011,Pages1382-1387
SeanCarroll,CostasTsakirides,JamesHobkirk,JamesW.A.Moxon,JamesW.D.Moxon,MichaelDudfield,LeeIngle
Closepreview | Relatedarticles | Relatedreferenceworkarticles
AbstractAbstract|Figures/TablesFigures/Tables|ReferencesReferences
Abstract
CarrollS,TsakiridesC,HobkirkJ,MoxonJWA,MoxonJWD,DudfieldM,IngleL.DifferentialimprovementsinlipidprofilesandFraminghamrecurrentriskscoreinpatientswithandwithoutdiabetesmellitusundergoinglong-termcardiacrehabilitation.
Objective
Todeterminewhetherlipidprofilesandrecurrentcoronaryheartdisease(CHD)riskcouldbemodifiedinpatientswithandwithoutdiabetesmellitusunder